Financials

News Discussions Technicals Forecast Seasonals

SLXN fundamentals

Overview Statements Statistics Dividends Earnings Revenue

The current financial position of Silexion Therapeutics Corp

Total assets of SLXN for Q2 24 is 5.97 M USD, 2.13% more than the previous Q1 24. And total liabilities increased by 7.36% in Q2 24 to 3.43 M USD.

Q4 '22

Q1 '23

Q2 '23

Q3 '23

Q4 '23

Q1 '24

Q2 '24

‪0.00‬

Total assets

Total liabilities

Income statement Balance sheet Cash flow

Currency: USD

Q4 '22

Q1 '23

Q2 '23

Q3 '23

Q4 '23

Q1 '24

Q2 '24

YoY growth

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—